The Most Influential Women in Healthcare Who Are Quietly Rewriting the Rules

Spend a day in pretty much any hospital and you’ll notice something the org chart doesn’t really capture. Most of the workforce is women — nurses, lab techs, the people scheduling your MRI, the ones who actually keep the place running. The corner offices used to tell a different story though. For a long time leadership skewed male even while the floor underneath it didn’t.

That’s shifting. Not overnight, but it’s shifting. A lot of the people setting the agenda in healthcare right now — physicians, hospital CEOs, biotech founders, public health officials — are women, and they didn’t just climb into the role. Several of them changed what the role even means once they got there. This piece is about a handful of those women, what they’ve actually built or changed, and why any of it matters past the walls of one hospital.

Why Bother With Another “Influential Women” List

I get the skepticism. “Most influential women in [industry]” is the kind of headline that shows up every March and then disappears until next year. But healthcare touches basically everyone alive, so the decisions made near the top of it — which drugs get funded, which tech gets built, which neighborhood gets a clinic and which one doesn’t — aren’t abstract. They show up in someone’s actual life.

Women bring a different read on a lot of these calls, often because they’ve had to navigate a system that wasn’t built with them in charge. You see it in maternal health programs that finally get real budget instead of a press release. You see it in telehealth tools designed around how people actually live, not around a hospital’s preferred scheduling block. You see it in burnout finally getting treated as a real cost instead of something nurses are just supposed to absorb. None of that is theoretical. It shows up in outcomes.

The Ones Who Built the Foundation

Before getting into who’s running things now, it’s worth slowing down on the people who made a lot of this possible in the first place — because some of this history gets flattened into a single sentence on a museum plaque, and it deserves more than that.

Florence Nightingale is the obvious one. Everybody knows the lamp, fewer people know that her real contribution was dragging sanitation and basic record-keeping into a Crimean War hospital that badly needed both. That insistence on data became, more or less, the template modern nursing education still runs on.

Marie Curie gets filed under physics, understandably, but her work on radioactivity ended up underpinning cancer treatment decades after she died. She wasn’t trying to revolutionize oncology. It happened anyway.

Helen Brooke Taussig pioneered pediatric cardiology and figured out how to treat what doctors at the time called “blue baby syndrome.” That single contribution gave a whole generation of infants a shot they wouldn’t have had otherwise.

Cicely Saunders started the modern hospice movement, and she had to argue for it — the idea that dying people deserved dignity and real pain management, not just a bed somewhere out of the way, wasn’t obvious to the medical establishment at the time.

And Mary Eliza Mahoney, the first Black professional nurse in the U.S., co-founded the National Association of Colored Graduate Nurses at a time when that door had been nailed shut on purpose.

None of these women just had jobs. They built parts of the field that didn’t exist before they showed up to it.

Who’s Doing It Now

Today’s version of this list spans way more ground than it used to — clinical leadership, sure, but also biotech, policy, digital health.

Take Judy Faulkner. She built Epic Systems, the medical records platform running inside places like the Mayo Clinic, starting out of her basement. The scale of that is impressive on its own, but what actually sticks with me is that she’s pledged most of her wealth to charity rather than just sitting on it.

Reshma Kewalramani runs Vertex Pharmaceuticals as president and CEO. Her handling of the company’s drug pipeline has gotten her onto lists of the most powerful people in business, full stop — not just healthcare. That’s worth noticing, because it means women aren’t only running hospitals anymore. They’re running the pharma companies deciding which drugs even make it to a patient.

Madeline Bell, CEO of Children’s Hospital of Philadelphia, started there as a nurse back in the 1980s before working her way through administration over three decades. Under her, CHOP built out its pediatric ambulatory-care network and reworked its residency program — the kind of change that usually comes from someone who’s actually stood on the floor at 2 a.m., not someone who just read about it in a report.

Jennifer Taubert oversees Johnson & Johnson’s innovative medicine division as EVP, which puts her in the room deciding which drugs in one of the largest portfolios on earth actually reach patients and how fast that happens.

Mandy Cohen has moved through senior public health roles, including at the CDC and at the state level, working on the opioid crisis, Medicaid policy, early childhood health. That’s the unglamorous seam between medicine and government — and honestly, that’s usually where the real influence lives, even if it doesn’t make headlines.

These aren’t five disconnected stories I stitched together for a listicle. They’re evidence of an actual pattern: women increasingly deciding budgets, setting research priorities, deciding who gets seen first.

What Keeps Showing Up

A few things repeat across nearly all of these, no matter the role.

Most started on the clinical or frontline side before moving into administration. That tends to produce decisions grounded in how care actually happens at 7am on a Tuesday, not just how it looks on a slide deck.

There’s also a steady push toward equity — closing gaps in maternal health, expanding access in places that have historically been ignored, chipping away at the structural stuff that kept women and minorities out of medicine’s upper ranks for generations.

And technology keeps coming up, but rarely as a flex. Whether it’s electronic records, AI diagnostics, or telehealth, the leaders pushing it tend to frame it as a way to reach more people, not a feature to brag about in a press release.

Where This Is Headed

The gap hasn’t closed. Not even close, really — women still hold a smaller share of CEO and board seats than their share of the healthcare workforce would suggest, by a wide margin. But the trend line is obvious, and the list of names worth knowing keeps getting longer every year, not shorter. What makes any of this worth tracking isn’t the awards ceremony. It’s whether a rural clinic gets real funding instead of a token grant, whether a new drug reaches patients a year sooner, whether a hospital treats its nursing staff like the backbone of the place instead of something replaceable. By that measure, the women in this article — and plenty more who haven’t made a list yet, and probably never will — are already changing what healthcare looks like for everyone who depends on it. Which, eventually, is all of us.